Edition:
United States

Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

245.37USD
24 Feb 2017
Change (% chg)

$-1.66 (-0.67%)
Prev Close
$247.03
Open
$246.11
Day's High
$246.42
Day's Low
$243.98
Volume
415,950
Avg. Vol
1,058,004
52-wk High
$301.12
52-wk Low
$184.58

Select another date:

Tue, Feb 14 2017

BRIEF-Allergan says Goldman Sachs Group reported 6.3 pct passive stake in co as of Dec. 31 - SEC filing

* The Goldman Sachs Group Inc reports 6.3 percent passive stake in Allergan Plc as of dec. 31, 2016 - sec filing Source text: (http://bit.ly/2knWz9s) Further company coverage:

Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion

Botox maker Allergan Plc <AGN.N,> agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people slim down by freezing fat away to the company's line-up of aesthetic products.

UPDATE 4-Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 bln

Feb 13 Botox maker Allergan Plc <AGN.N,> agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people slim down by freezing fat away to the company's line-up of aesthetic products.

Allergan adds ice and a slice to M&A cocktail

NEW YORK (Reuters Breakingviews) - Allergan has added ice and a slice to its M&A cocktail. The drug company is paying just under $2.5 billion for Zeltiq Aesthetics and its diet-avoiding, fat-freezing tech. It sounds a wackier play than the dozen deals Allergan struck last year. But vain customers pay cold cash for the treatment, making it less speculative than other acquisitions, like gene therapy.

CORRECTED-UPDATE 2-Allergan to buy Zeltiq Aesthetics for about $2.48 bln

Feb 13 Botox maker Allergan Plc said it would buy body-contouring product maker Zeltiq Aesthetics Inc for about $2.48 billion, adding muscle to its line-up of products used to fight fat and smoothen wrinkles.

BRIEF-Allergan agrees to acquire Zeltiq for $2.48 bln

* Allergan has agreed to acquire Zeltiq for $56.50 per share, or $2.475 billion

Allergan agrees to buy Zeltiq for about $2.48 bln

Feb 13 Allergan Plc on Monday said it would buy Zeltiq Aesthetics Inc for about $2.48 billion to gain access to its flagship body contouring technology.

BRIEF-Third Point LLC takes share stake in JPMorgan, Bank of America - SEC Filing

* Third Point Llc dissolves share stake in Allergan Plc - SEC Filing

Allergan says U.S. tax reform unlikely in 2017, sees strong year

Allergan Plc Chief Executive Brent Saunders said on Wednesday he does not anticipate U.S. tax reforms this year and that an import tax could hurt the Dublin-based drugmaker.

UPDATE 3-Allergan says U.S. tax reform unlikely in 2017, sees strong year

* Shares rise as much as 2.6 pct (Adds detail, analyst comment)

Select another date:

More From Around the Web